Cargando…
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective
The advent of biologic agents has provided a more specific and targeted approach to the treatment of various hematological malignancies and other autoimmune disorders. Such biologic agents have been relatively well tolerated with fewer adverse events reported as compared with many other chemotherape...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580676/ https://www.ncbi.nlm.nih.gov/pubmed/22967460 http://dx.doi.org/10.1186/cc11304 |